Clincosm LogoSign in Get a demo

Acute Myeloid Leukemia

Showing NaN - NaN of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Biospecimen Collection
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Acute Myeloid Leukemia Trial in Worldwide (Quizartinib, Intrathecal (IT) triple chemo prophylaxis, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Loma Linda, California
  • +36 more
Feb 1, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Anchorage, Alaska
  • +506 more
Jan 28, 2023

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +3 more
  • Little Rock, Arkansas
  • +82 more
Jan 17, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Acute Myeloid Leukemia Trial in United States (TAS1440, TAS1440 + ATRA)

Recruiting
  • Acute Myeloid Leukemia
  • Tucson, Arizona
  • +8 more
Jan 3, 2023

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax)

Completed
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Nov 7, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 18, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Seattle (SC-DARIC33)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • SC-DARIC33
  • Seattle, Washington
    Seattle Children's Hospital
Sep 6, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Acute Myeloid Leukemia Trial in United States (Cyclophosphamide, Fludarabine, KITE-222)

Recruiting
  • Acute Myeloid Leukemia
  • Stanford, California
  • +6 more
Aug 10, 2022

Acute Myeloid Leukemia Trial in Worldwide (TL-895, KRT-232)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +33 more
Aug 3, 2022

Acute Myeloid Leukemia Trial in Worldwide (SEL24/MEN1703)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Atlanta, Georgia
  • +14 more
Aug 3, 2022